KPV
$71.50Price
In biomedical research, KPV is investigated as a targeted anti-inflammatory and immunomodulatory tripeptide for preclinical models of inflammatory bowel disease (IBD), colitis, autoimmune skin pathologies such as psoriasis and contact dermatitis, and localized peptide-based drug delivery systems via PepT1 transporter mechanisms.